Single‐dose pharmacokinetics and bioavailability of famotidine in man. Results of multicenter collaborative studies
Authors:
- 1 November 1987
- journal article
- research article
- Published by Wiley in Biopharmaceutics & Drug Disposition
- Vol. 8 (6) , 549-560
Abstract
Pharmacokinetics and bioavailability of famotidine, a new H2‐receptor antagonist, were investigated in healthy subjects in five clinical studies. Linear pharmacokinetics were observed following either intravenous or oral administration. Plasma clearance averaged 463 ml min−1. Renal clearance averaged 310 ml min−1, which exceeded the glomerular filtration rate. Renal excretion was the major route of elimination. Urinary recovery of unchanged drug following intravenous administration was about 67 per cent. Famotidine plasma half‐life was approximately 2.6h. Oral absorption was incomplete. The bioavailability averaged 43 per cent of the dose.Keywords
This publication has 17 references indexed in Scilit:
- MK-208, a novel histamine H2-receptor inhibitor with prolonged antisecretory effectDigestive Diseases and Sciences, 1985
- Analytical method for the quantification of famotidine, an H2-receptor blocker, in plasma and urineJournal of Chromatography B: Biomedical Sciences and Applications, 1985
- Studies on the H2-receptor antagonism of MK-208 in isolated rabbit gastric glandsEuropean Journal of Pharmacology, 1984
- Ranitidine bioavailability and kinetics in normal male subjectsClinical Pharmacology & Therapeutics, 1983
- Ranitidine: single dose pharmacokinetics and absolute bioavailability in man.British Journal of Clinical Pharmacology, 1982
- Ranitidine kinetics in normal subjectsClinical Pharmacology & Therapeutics, 1982
- Ranitidine kinetics and dynamics: II. Intravenous dose studies and comparison with cimetidineClinical Pharmacology & Therapeutics, 1981
- Pharmacokinetics of the H2‐ receptor antagonist ranitidine in man.British Journal of Clinical Pharmacology, 1981
- A comparison of numerical integrating algorithms by trapezoidal, Lagrange, and spline approximationJournal of Pharmacokinetics and Biopharmaceutics, 1978
- Novel Method for Bioavailability AssessmentJournal of Pharmaceutical Sciences, 1973